Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells

Efficient and specific delivery of nucleic acid (NA) therapeutics to tumor cells is extremely important for cancer gene therapy. Various therapeutic strategies include delivery of DNA-therapeutics such as immunostimulatory or suicide genes and delivery of siRNA-therapeutics able to silence expressio...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Anna Egorova, Alexander Selutin, Marianna Maretina, Sergei Selkov, Vladislav Baranov, Anton Kiselev
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Subjects:	nonviral gene delivery siRNA delivery receptor targeting peptide-based carriers integrin iRGD
Online Access:	https://www.mdpi.com/1424-8247/13/10/300

Similar Items

Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
by: Anna Egorova, et al.
Published: (2022-11-01)

Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
by: Yu Zhou, et al.
Published: (2019-12-01)

Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide
by: Eltayeb E. M. Eid, et al.
Published: (2019-07-01)

iRGD‐Targeted Physalis Mottle Virus Like Nanoparticles for Targeted Cancer Delivery
by: Krister J. Barkovich, et al.
Published: (2023-08-01)

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
by: Anna Egorova, et al.
Published: (2023-08-01)

Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
by: Anna Egorova, et al.
Published: (2021-02-01)

Preparation and characterization of a iRGD-modified recombinant spider silk particles for antitumor polypeptide drug delivery into cancer cells
by: Ben Wang, et al.
Published: (2025-08-01)

iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
by: Yanbing Dong, et al.
Published: (2023-03-01)

Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide
by: Gye Lim Kim, et al.
Published: (2023-02-01)

Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model
by: Zheng-Hong Peng, et al.
Published: (2022-08-01)

iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma
by: Liu T, et al.
Published: (2025-01-01)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
by: Dan Lin, et al.
Published: (2021-12-01)

Molecular Imaging of Steroid-Induced Osteonecrosis of the Femoral Head through iRGD-Targeted Microbubbles
by: Ping Zhao, et al.
Published: (2022-09-01)

The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
by: Yingzheng Wang, et al.
Published: (2023-09-01)

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade
by: Yirong Wu, et al.
Published: (2025-05-01)

Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
by: Jie Shao, et al.
Published: (2024-12-01)

Click Chemistry for the Synthesis of RGD-Containing Integrin Ligands
by: Matteo Colombo, et al.
Published: (2010-01-01)

LIC12254 Is a Leptospiral Protein That Interacts with Integrins via the RGD Motif
by: Maria F. Cavenague, et al.
Published: (2023-04-01)

iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer
by: Hou X, et al.
Published: (2024-08-01)

Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
by: Atieh Yaghoubi, et al.
Published: (2023-07-01)

Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy
by: Yun Wu, et al.
Published: (2013-11-01)

Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine–Glycine–Aspartate) Strategies
by: Bojana Bogdanović, et al.
Published: (2024-11-01)

iRGD Tumor-Penetrating Peptide-Modified Nano-Delivery System Based on a Marine Sulfated Polysaccharide for Enhanced Anti-Tumor Efficiency Against Breast Cancer
by: Chen B, et al.
Published: (2022-02-01)

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
by: Xiaolin Yu, et al.
Published: (2021-12-01)

HER-2 Receptor and αvβ3 Integrin Dual-Ligand Surface-Functionalized Liposome for Metastatic Breast Cancer Therapy
by: Dilip Kumar Arya, et al.
Published: (2024-08-01)

αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment
by: Prashant Pandey, et al.
Published: (2024-08-01)

Tumor targeting via integrin ligands
by: Udaya Kiran eMarelli, et al.
Published: (2013-08-01)

Status and Advances of RGD Molecular Imaging in Lung Cancer
by: Ning YUE, et al.
Published: (2014-12-01)

Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens
by: Hiroaki Echigo, et al.
Published: (2021-10-01)

Integrin-Mediated Delivery of Drugs and Nucleic Acids for Anti-Angiogenic Cancer Therapy: Current Landscape and Remaining Challenges
by: Poulami Majumder
Published: (2018-09-01)

Intraocular siRNA Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene
by: Xin Gao, et al.
Published: (2023-02-01)

Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy
by: Tsai-Mu Cheng, et al.
Published: (2021-07-01)

Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues
by: Jordan Cossu, et al.
Published: (2023-02-01)

Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials
by: Junwei Zhao, et al.
Published: (2020-08-01)

Dissociation Constant of Integrin-RGD Binding in Live Cells from Automated Micropipette and Label-Free Optical Data
by: Tamás Gerecsei, et al.
Published: (2021-01-01)

Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia
by: Breanne Landry, et al.
Published: (2015-01-01)

Design and synthesis of hydrophobic RGD-peptides derivatives
by: A. V. Dobrynina, et al.
Published: (2010-02-01)

Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein
by: Lee Makowski, et al.
Published: (2021-01-01)

Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
by: Afsana Sheikh, et al.
Published: (2022-01-01)

The use of integrin binding domain loaded hydrogel (RGD) with minimally invasive surgical technique in treatment of periodontal intrabony defect: a randomized clinical and biochemical study
by: Shaimaa Hamdy ABD EL-AZEEM, et al.
Published: (2023-12-01)